Patent litigation has produced a complex settlement landscape with multiple generic manufacturers entering at staggered dates
The other thing, and this is not editorial, this is a real observation, pharmaceutical companies are very interested in the other uses of already approved drugs
But targeting GLP-1 receptors in the brain will likely need a small molecule drug
Isaacs said more GLP-based medications are on the horizon, including new injectables and lower-cost oral versions expected in the coming years
Stress management practices like meditation, deep breathing, yoga, nature exposure, and social connection mitigate these effects
A different peptide (AHK-Cu), specifically designed for hair follicles